Description

Clindamycin Heptadecanoate is a high-purity pharmaceutical intermediate, specifically a long-chain fatty acid ester derivative of the antibiotic clindamycin. This compound is critical for the development and production of specialized, long-acting clindamycin formulations. It is primarily utilized by pharmaceutical R&D departments and manufacturers focused on creating advanced drug delivery systems, such as depot injections and topical applications, where sustained release is required.

Application

• Pharmaceutical Intermediate: Key starting material for synthesizing novel, long-acting prodrugs of clindamycin.
• Sustained-Release Formulations: Development of depot injections and implants designed for prolonged antibiotic delivery.
• Topical Drug Delivery: Research into creams, gels, and ointments for enhanced skin penetration and localized, sustained action.
• Antibiotic Research: Used in academic and industrial research to study structure-activity relationships and new antibacterial agents.
• Veterinary Pharmaceuticals: Potential application in developing long-acting antibiotic treatments for animals.

Basic Information

Product Name	Clindamycin Heptadecanoate
CAS No.	1123211-69-7
Molecular Formula	C34H65ClN2O5S
Molecular Weight	641.41 g/mol
Synonyms	Clindamycin Margarate; Clindamycin C17:0; Clindamycin Heptadecylate; (2S,4R)-N-[(1S,2S)-2-Chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxylic acid heptadecanoate ester; Heptadecanoic acid, 2-[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyloxy]-1,2-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-ribo-hexopyranosyl)-6-(methylthio)-, (2R,3S,4R,5R,6S)- (ester); Lincosamide antibiotic derivative
EINECS	Contact for details

Quality Control

Our Clindamycin Heptadecanoate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, identity confirmation by IR and NMR, and residual solvent analysis, to ensure it meets the stringent requirements for pharmaceutical intermediate use. A Certificate of Analysis (COA) detailing all specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.